Angiotensin II increases fibronectin and collagen I through the β-catenin-dependent signaling in mouse collecting duct cells

American Journal of Physiology - Renal Physiology

Volumn 308, Issue 4, 2015, Pages F358-F365

  Cuevas, Catherina A ^a,c   Gonzalez, Alexis A ^b   Inestrosa, Nibaldo C ^a   Vio, Carlos P ^a   Prieto, Minolfa C ^c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Mouse collecting duct cell; Pyrvinium pamoate; Tissue homeostasis

Indexed keywords

ANGIOTENSIN II; BETA CATENIN; CANDESARTAN; COLLAGEN TYPE 1; CYCLIN D1; FIBRONECTIN; GLYCOGEN SYNTHASE KINASE 3; MYC PROTEIN; PYRVINIUM EMBONATE; ACTIN; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CCND1 PROTEIN, MOUSE; CTNNB1 PROTEIN, MOUSE; GLYCOGEN SYNTHASE KINASE 3 BETA; MESSENGER RNA; MYC PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HOMEOSTASIS; KIDNEY COLLECTING TUBULE; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; AGONISTS; ANIMAL; CELL LINE; DRUG EFFECTS; GENETICS; METABOLISM; MYOFIBROBLAST; PHENOTYPE; PHOSPHORYLATION; TIME FACTOR;

ACTINS; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BETA CATENIN; CELL LINE; COLLAGEN TYPE I; CYCLIN D1; FIBRONECTINS; GLYCOGEN SYNTHASE KINASE 3; KIDNEY TUBULES, COLLECTING; MICE; MYOFIBROBLASTS; PHENOTYPE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION;

EID: 84922879859     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00429.2014     Document Type: Article

References (52)

1. Anderson PW, Do YS, Hsueh WA. Angiotensin II causes mesangial cell hypertrophy. Hypertension 21: 29–35, 1993.
2. Butt MJ, Tarantal AF, Jimenez DF, Matsell DG. Collecting duct epithelial-mesenchymal transition in fetal urinary tract obstruction. Kidney Int 72: 936–944, 2007.
3. Cho MH. Renal fibrosis. Korean J Pediatr 53: 735–740, 2010.
4. Christensen BM, Kim YH, Kwon TH, Nielsen S. Lithium treatment induces a marked proliferation of primarily principal cells in rat kidney inner medullary collecting duct. Am J Physiol Renal Physiol 291: F39–F48, 2006.
5. Christensen BM, Marples D, Kim YH, Wang WD, Frokiær J, Nielsen S. Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI. Am J Physiol Cell Physiol 286: C952–C964, 2004.
6. 1 receptors. Hypertension 37: 604–608, 2001.
7. Diez J, Panizo A, Hernandez M, Galindo MF, Cenarruzabeitia E, Pardo Mindan FJ. Quinapril inhibits c-Myc expression and normalizes smooth muscle cell proliferation in spontaneously hypertensive rats. Am J Hypertens 10: 1147–1152, 1997.
8. Dutta UK, Lane J, Roberts LJ, Majid DS. Superoxide formation and interaction with nitric oxide modulate systemic arterial pressure and renal function in salt-depleted dogs. Exp Biol Med (Maywood) 231: 269–276, 2006.
9. Eastman Q, Grosschedl R. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 11: 233–240, 1999.
10. Gilbert RE, Wu LL, Kelly DJ, Cox A, Wilkinson-Berka JL, Johnston CI, Cooper ME. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol 155: 429–440, 1999.
11. Gonzalez AA, Liu L, Lara LS, Seth DM, Navar LG, Prieto MC. Angiotensin II stimulates renin in inner medullary collecting duct cells via protein kinase C and independent of epithelial sodium channel and mineralocorticoid receptor activity. Hypertension 57: 594–599, 2011.
12. Guillemot L, Levy A, Raymondjean M, Rothhut B. Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT(1A) cells. J Biol Chem 276: 39394–39403, 2001.
13. Guo Y, Xiao L, Sun L, Liu F. Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res 61: 337–346, 2012.
14. 1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol Renal Physiol 273: F170–F177, 1997.
15. He W, Dai C, Li Y, Zeng G, Monga SP, Liu Y. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20: 765–776, 2009.
16. Ho C, Lee PH, Hsu YC, Wang FS, Huang YT, Lin CL. Sustained Wnt/beta-catenin signaling rescues high glucose induction of transforming growth factor-beta1-mediated renal fibrosis. Am J Med Sci 344: 374–382, 2012.
17. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47: 1285–1294, 1995.
18. Ivanova L, Butt MJ, Matsell DG. Mesenchymal transition in kidney collecting duct epithelial cells. Am J Physiol Renal Physiol 294: F1238– F1248, 2008.
19. Jinde K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC, Lan HY. Tubular phenotypic change in progressive tubulo-interstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 38: 761–769, 2001.
20. Jonassen JA, Agustin JS, Follit JA, Pazour GJ. Deletion of IFT20 in the mouse kidney causes misorientation of the mitotic spindle and cystic kidney disease. J Cell Biol 183: 377–384, 2008.
21. Kolesnyk I, Struijk DG, Dekker FW, Krediet RT. Effects of angioten-sin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease. Neth J Med 68: 15–23, 2010.
22. Kucherenko Y, Zelenak C, Eberhard M, Qadri SM, Lang F. Effect of casein kinase 1 alpha activator pyrvinium pamoate on erythrocyte ion channels. Cell Physiol Biochem 30: 407–417, 2012.
23. 1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension. Am J Physiol Renal Physiol 302: F85–F94, 2012.
24. Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ. Chronic kidney disease: common, harmful, and treatable–World Kidney Day 2007. Clin J Am Soc Nephrol 2: 401–405, 2007.
25. Lovatt M, Bijlmakers MJ. Stabilisation of beta-catenin downstream of T cell receptor signaling. PLos One 5: e12794, 2010.
26. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82–C97, 2007.
27. Mezzano SA, Ruiz-Ortega M, Egido J. Angiotensin II and renal fibrosis. Hypertension 38: 635–638, 2001.
28. Mologni L, Dekhil H, Ceccon M, Purgante S, Lan C, Cleris L, Magistroni V, Formelli F, Gambacorti-Passerini CB. Colorectal tumors are effectively eradicated by combined inhibition of beta-catenin, KRAS, and the oncogenic transcription factor ITF2. Cancer Res 70: 7253–7263, 2010.
29. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured vascular smooth muscle cells. J Clin Invest 83: 1412–1419, 1989.
30. Nakopoulou L, Lazaris AC, Boletis IN, Michail S, Giannopoulou I, Zeis PM, Stathakis CP, Davaris PS. Evaluation of E-cadherin/catenin complex in primary and secondary glomerulonephritis. Am J Kidney Dis 39: 469–474, 2002.
31. Nusse R. Wnt signaling. Cold Spring Harb Perspect Biol 4: pii: a011163, 2012.
32. Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 272: 24735–24738, 1997.
33. Presne C, Fakhouri F, Noel LH, Stengel B, Even C, Kreis H, Mignon F, Grunfeld JP. Lithium-induced nephropathy: rate of progression and prognostic factors. Kidney Int 64: 585–592, 2003.
34. Quiroz JA, Gould TD, Manji HK. Molecular effects of lithium. Mol Interv 4: 259–272, 2004.
35. Rao R, Zhang MZ, Zhao M, Cai H, Harris RC, Breyer MD, Hao CM. Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxy-genase 2-dependent polyuria. Am J Physiol Renal Physiol 288: F642– F649, 2005.
36. Rastaldi MP, Ferrario F, Giardino L, Dell’Antonio G, Grillo C, Grillo P, Strutz F, Muller GA, Colasanti G, D’Amico G. Epithelial-mesen-chymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62: 137–146, 2002.
37. Ruiz-Ortega M, Ruperez M, Esteban V, Egido J. Molecular mechanisms of angiotensin II-induced vascular injury. Curr Hypertens Rep 5: 73–79, 2003.
38. Saraswati S, Alfaro MP, Thorne CA, Atkinson J, Lee E, Young PP. Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling. PLos One 5: e15521, 2010.
39. Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, Maeshima Y, Sugyama H, Sugaya T, Murakami K, Makino H. Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 12: 317–325, 2001.
40. Satoh M, Nagasu H, Morita Y, Yamaguchi TP, Kanwar YS, Kashi-hara N. Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling. Am J Physiol Renal Physiol 303: F1641–F1651, 2012.
41. Schulman IH, Zhou MS, Treuer AV, Chadipiralla K, Hare JM, Raij L. Altered renal expression of angiotensin II receptors, renin receptor, and ACE-2 precede the development of renal fibrosis in aging rats. Am J Nephrol 32: 249–261, 2010.
42. Shao W, Seth DM, Prieto MC, Kobori H, Navar LG. Activation of the renin-angiotensin system by a low salt diet does not augment intratubular angiotensinogen and angiotensin II in rats. Am J Physiol Renal Physiol 304: F505–F514, 2013.
43. Shimizu T, Kagawa T, Inoue T, Nonaka A, Takada S, Aburatani H, Taga T. Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells. Mol Cell Biol 28: 7427–7441, 2008.
44. Surendran K, Schiavi S, Hruska KA. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol 16: 2373–2384, 2005.
45. Thorne CA, Hanson AJ, Schneider J, Tahinci E, Orton D, Cselenyi CS, Jernigan KK, Meyers KC, Hang BI, Waterson AG, Kim K, Melancon B, Ghidu VP, Sulikowski GA, LaFleur B, Salic A, Lee LA, Miller DM, Lee E. Small-molecule inhibition of Wnt signaling through activation of casein kinase 1 alpha. Nat Chem Biol 6: 829–836, 2010.
46. Touyz RM, Schiffrin EL. Increased generation of superoxide by angio-tensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens 19: 1245–1254, 2001.
47. 1 receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyp1a1-Ren2 transgenic rats fed with a high-salt diet. Am J Med Sci 339: 356–361, 2010.
48. Wolf G. The renin-angiotensin system and progression of renal diseases. Hamburg: Karger, 2002.
49. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-B. J Clin Invest 92: 1366–1372, 1993.
50. Wolf G, Neilson EG. Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol Renal Fluid Electrolyte Physiol 259: F768–F777, 1990.
51. Wolf G, Wenzel UO. Angiotensin II and cell cycle regulation. Hypertension 43: 693–698, 2004.
52. Yang S, Yao B, Zhou Y, Yin H, Zhang MZ, Harris RC. Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury. Am J Physiol Renal Physiol 302: F742–F749, 2012.